| Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia MR Grever, O Abdel-Wahab, LA Andritsos, V Banerji, J Barrientos, ... Blood, The Journal of the American Society of Hematology 129 (5), 553-560, 2017 | 258 | 2017 |
| Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia RJ Kreitman, C Dearden, PL Zinzani, J Delgado, L Karlin, T Robak, ... Leukemia 32 (8), 1768-1777, 2018 | 252 | 2018 |
| Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial MA Dimopoulos, F Gay, F Schjesvold, M Beksac, R Hajek, KC Weisel, ... The Lancet 393 (10168), 253-264, 2019 | 242 | 2019 |
| The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model T Tadmor, Y Zhang, HM Cho, ER Podack, JD Rosenblatt Cancer Immunology, Immunotherapy 60, 609-619, 2011 | 151 | 2011 |
| Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing YC Cohen, M Zada, SY Wang, C Bornstein, E David, A Moshe, B Li, ... Nature medicine 27 (3), 491-503, 2021 | 143 | 2021 |
| Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options A Aviv, T Tadmor, A Polliack Annals of oncology 24 (9), 2236-2244, 2013 | 140 | 2013 |
| Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination Y Herishanu, G Rahav, S Levi, A Braester, G Itchaki, O Bairey, N Dally, ... Blood, The Journal of the American Society of Hematology 139 (5), 678-685, 2022 | 105 | 2022 |
| Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties T Tadmor, A Aviv, A Polliack Annals of Oncology 22 (2), 250-256, 2011 | 100 | 2011 |
| Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia O Benjamini, L Rokach, G Itchaki, A Braester, L Shvidel, N Goldschmidt, ... Haematologica 107 (3), 625, 2022 | 99 | 2022 |
| Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre-and post … T Tadmor, A Bari, S Sacchi, L Marcheselli, EV Liardo, I Avivi, N Benyamini, ... haematologica 99 (1), 125, 2014 | 95 | 2014 |
| Absolute monocytosis at diagnosis correlates with survival in diffuse large B‐cell lymphoma—possible link with monocytic myeloid‐derived suppressor cells T Tadmor, R Fell, A Polliack, D Attias Hematological oncology 31 (2), 65-71, 2013 | 95 | 2013 |
| First-line venetoclax combinations in chronic lymphocytic leukemia B Eichhorst, CU Niemann, AP Kater, M Fürstenau, J Von Tresckow, ... New England Journal of Medicine 388 (19), 1739-1754, 2023 | 94 | 2023 |
| CD30: an important new target in hematologic malignancies YE Deutsch, T Tadmor, ER Podack, JD Rosenblatt Leukemia & lymphoma 52 (9), 1641-1654, 2011 | 93 | 2011 |
| B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion Y Zhang, Y Eliav, S Shin, TH Schreiber, ER Podack, T Tadmor, ... Cancer Immunology, Immunotherapy 62, 87-99, 2013 | 91 | 2013 |
| The expression of lysyl‐oxidase gene family members in myeloproliferative neoplasms T Tadmor, J Bejar, D Attias, E Mischenko, E Sabo, G Neufeld, Z Vadasz American journal of hematology 88 (5), 355-358, 2013 | 84 | 2013 |
| COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study T Chatzikonstantinou, A Kapetanakis, L Scarfò, G Karakatsoulis, D Allsup, ... Leukemia 35 (12), 3444-3454, 2021 | 76 | 2021 |
| Myeloid‐derived suppressor cells–their role in haemato‐oncological malignancies and other cancers and possible implications for therapy T Tadmor, D Attias, A Polliack British journal of haematology 153 (5), 557-567, 2011 | 76 | 2011 |
| Predicting infections in high‐risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study D Merkel, K Filanovsky, A Gafter‐Gvili, L Vidal, A Aviv, ME Gatt, ... American journal of hematology 88 (2), 130-134, 2013 | 72 | 2013 |
| Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy K Jamroziak, T Tadmor, T Robak, A Polliack Leukemia & lymphoma 56 (7), 1949-1958, 2015 | 71 | 2015 |
| Ibrutinib‐associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non‐Hodgkin lymphoma: an observational study R Ruchlemer, R Ben‐Ami, M Bar‐Meir, JR Brown, M Malphettes, R Mous, ... Mycoses 62 (12), 1140-1147, 2019 | 61 | 2019 |
